Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Elite Pharma Inc (ELTP)

Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Elite Pharma Inc 165 LUDLOW AVENUE NORTHVALE NJ 07647 USA

www.elitepharma.com P: 201-750-2646

Description:

Elite Pharmaceuticals, Inc. primarily engages in researching, developing, licensing, manufacturing, and marketing proprietary drug delivery systems and products. Their drug delivery technology involves releasing a drug into the bloodstream or delivering it to a target site in the body over an extended period of time or at predetermined times.

Key Statistics

Overview:

Market Capitalization, $K 408,614
Enterprise Value, $K 405,084
Shares Outstanding, K 1,068,273
Annual Sales, $ 56,630 K
Annual Net Income, $ 20,110 K
Last Quarter Sales, $ 18,800 K
Last Quarter Net Income, $ 620 K
EBIT, $ 14,530 K
EBITDA, $ 16,000 K
60-Month Beta 0.18
% of Insider Shareholders 14.42%
% of Institutional Shareholders 0.01%
Float, K 914,228
% Float 85.58%
Short Volume Ratio 0.51

Growth:

1-Year Return 373.14%
3-Year Return 755.41%
5-Year Return 307.89%
5-Year Revenue Growth 648.08%
5-Year Earnings Growth 400.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 08/14/24
Next Earnings Date N/A
Earnings Per Share ttm 0.01
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ELTP Ratios

Ratio
Price/Earnings ttm 38.98
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 40.72%
Return-on-Assets % 26.64%
Profit Margin % 35.51%
Debt/Equity 0.13
Price/Sales 7.35
Price/Cash Flow 12.27
Price/Book 6.60
Book Value/Share 0.05
Interest Coverage -1.78
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar